Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018 Tongtong Wang; Yuzhi Xi; Annaswamy Raji; Michael Crutchlow; Gail Fernandes; Samuel S Engel; Xiao Zhang;

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists Lucy Gracen; Withma Muthukumara; Melanie Aikebuse; Anthony Russell; James O'Beirne; Katharine M. Irvine; Suzanne Williams; Gaurav Puri; Patricia C. Valery; Kelly L. Hayward; Elizabeth E. Powell;

Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network Marina Farah; Chimaobi Anugwom; Javier Diaz Ferrer; Estefania Liza Baca; Angelo Z. Mattos; João Pedro P. Possebon; Marco Arrese; Jhon Prieto; Domingo Balderramo; Enrique Carrera; Jose D. Debes;